CreativeOne Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

CreativeOne Wealth’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$356K	Sell	571 -88	-13%	-$59.9K	0.01%	927
2026 Q1	$509K	Sell	659 -123	-16%	-$94.2K	0.01%	801
2025 Q4	$604K	Buy	782 +119	+18%	+$80.8K	0.01%	731
2025 Q3	$373K	Sell	663 -113	-15%	-$63.9K	0.01%	867
2025 Q2	$407K	Buy	776 +256	+49%	+$143K	0.01%	809
2025 Q1	$330K	Buy	520 +74	+17%	+$50.9K	0.01%	831
2024 Q4	$318K	Buy	+446	New	+$374K	0.01%	854
2024 Q2	–	Sell	-208	Closed	-$200K	–	886
2024 Q1	$200K	Buy	+208	New	+$198K	0.01%	845
2023 Q2	–	Sell	-321	Closed	-$264K	–	881
2023 Q1	$264K	Sell	321 -7	-2%	-$5.28K	0.01%	673
2022 Q4	$237K	Buy	328 +37	+13%	+$27.3K	0.01%	648
2022 Q3	$200K	Buy	+291	New	+$183K	0.01%	665
2022 Q2	–	Sell	-357	Closed	-$249K	–	787
2022 Q1	$249K	Buy	+357	New	+$226K	0.01%	633

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

CreativeOne Wealth's REGN Position: Q2 2026 in Review

CreativeOne Wealth reduced its Regeneron Pharmaceuticals (REGN) stake by 13% in Q2 2026, selling an estimated $59.9K and leaving 571 shares worth $356K. The position accounts for 0.01% of the portfolio, ranked #927.

CreativeOne Wealth first reported a position in REGN in Q1 2022 and has held it in 12 quarters since. The position peaked at $604K in Q4 2025. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

CreativeOne Wealth held 571 shares of Regeneron Pharmaceuticals worth $356K as of Q2 2026.
CreativeOne Wealth sold 88 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $59.9K.
Regeneron Pharmaceuticals made up 0.01% of CreativeOne Wealth's portfolio in Q2 2026, its #927 holding.
CreativeOne Wealth first reported a position in Regeneron Pharmaceuticals in Q1 2022 and has held it in 12 quarters since.
CreativeOne Wealth's Regeneron Pharmaceuticals position peaked at $604K in Q4 2025.
1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on CreativeOne Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.